Kevin held the position of Vice President, Search and Evaluation at AbbVie, where he lead a global team of licensing professionals responsible for search, evaluation, and due diligence of all business development opportunities. Kevin has more than 25 years of pharmaceutical industry experience and for the last 14 years has worked in the Abbvie’s business development organization, both in scientific and transaction roles.
Previously, Kevin worked in Research as a molecular biologist and subsequently was a member of Abbott’s portfolio analysis and strategic decision support group. Before joining Abbott, Kevin worked in the Gene Medicine Department at Rhone-Poulenc Rorer Pharmaceuticals. Kevin received his Ph.D. in Microbiology and an NIH post-doctoral fellowship at the Pennsylvania State University, and holds an MBA from Northwestern University Kellogg School of Management.
Are you Recursion ready?
Join our passionate, innovative team—and help us realize our goal of 100 treatments by 2025.